MedTrace Logo

Frequency Specific Microcurrent Therapy for Mild Traumatic Brain Injury

NCT06245967 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-02-07

No results posted yet for this study

Summary

Patients with mild traumatic brain injury (mTBI) may experience spontaneous recovery within 7-10 days, but some continue to exhibit symptoms such as headache, dizziness, vertigo, poor concentration, and cognitive dysfunction. Effective treatments for these symptoms are currently lacking. Frequency Specific Microcurrent(FSM) has received approval from the U.S. FDA for use in neuroinflammatory conditions. Our study aims to evaluate the efficacy of FSM by using FSM device ,IS02LCDs Stimulator (Ru Yi Health ltd. Co,Taiwan R.O.C), on symptom improvement in 52 patients with mild TBI

Conditions

  • Trauma, Head
  • Headaches Posttraumatic
  • Dizziness
  • Brain Concussion
  • Frequency Specific Microcurrent Therapy

Interventions

DEVICE

Frequency specific microcurrent therapy

Concussion protocol

DEVICE

Sham Frequency specific microcurrent therapy

Shan concussion protocol

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • I HAN Hsiao · China Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-15
Primary Completion
2026-02-28
Completion
2026-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06245967 on ClinicalTrials.gov